Psychotropic medication use among nursing home residents in Austria: a cross-sectional study

Eva Mann, Sascha Köpke, Burkhard Haastert, Kaisu Pitkälä, Gabriele Meyer, Eva Mann, Sascha Köpke, Burkhard Haastert, Kaisu Pitkälä, Gabriele Meyer

Abstract

Background: The use of psychotropic medications and their adverse effects in frail elderly has been debated extensively. However, recent data from European studies show that these drugs are still frequently prescribed in nursing home residents. In Austria, prevalence data are lacking. We aimed to determine the prevalence of psychotropic medication prescription in Austrian nursing homes and to explore characteristics associated with their prescription.

Methods: Cross-sectional study and association analysis in forty-eight out of 50 nursing homes with 1844 out of a total of 2005 residents in a defined urban-rural region in Austria. Prescribed medication was retrieved from residents' charts. Psychotropic medications were coded according to the Anatomical Therapeutic Chemical Classification 2005. Cluster-adjusted multiple logistic regression analysis was performed to investigate institutional and residents' characteristics associated with prescription.

Results: Residents' mean age was 81; 73% of residents were female. Mean cluster-adjusted prevalence of residents with at least one psychotropic medication was 74.6% (95% confidence interval, CI, 72.0-77.2). A total of 45.9% (95% CI 42.7-49.1) had at least one prescription of an antipsychotic medication. Two third of all antipsychotic medications were prescribed for bedtime use only. Anxiolytics were prescribed in 22.2% (95% CI 20.0-24.5), hypnotics in 13.3% (95% CI 11.3-15.4), and antidepressants in 36.8% (95% CI 34.1-39.6) of residents. None of the institutional characteristics and only few residents' characteristics were significantly associated with psychotropic medication prescription. Permanent restlessness was positively associated with psychotropic medication prescription (AOR 1.54, 95% CI 1.32-1.79) whereas cognitive impairment was inversely associated (AOR 0.70, 95% CI 0.56-0.88).

Conclusion: Frequency of psychotropic medication prescription is high in Austrian nursing homes compared to recent published data from other countries. Interventions should aim at reduction and optimisation of prescriptions.

References

    1. Alanen HM, Finne-Soveri H, Noro A, Leinonen E. Use of antipsychotics among nonagenarian residents in long-term institutional care in Finland. Age Ageing. 2006;35:508–513. doi: 10.1093/ageing/afl065.
    1. Hosia-Randell H, Pitkälä K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging. 2005;22:793–800. doi: 10.2165/00002512-200522090-00008.
    1. Meyer G, Köpke S, Haastert B, Mühlhauser I. Restraint use among nursing home residents: cross-sectional study and prospective cohort study. J Clin Nurs. 2009;18:981–990. doi: 10.1111/j.1365-2702.2008.02460.x.
    1. Molter-Bock E, Hasford J, Pfundstein T. Psychopharmacological drug treatment in Munich nursing homes. [Article in German] Z Gerontol Geriatr. 2006;39:336–343. doi: 10.1007/s00391-006-0401-7.
    1. Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP, Lewis IK. Adverse drug events in high-risk older outpatients. J Am Geriatr Soc. 1997;45:945–948.
    1. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293:596–608. doi: 10.1001/jama.293.5.596.
    1. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews. 2006:CD003476.
    1. Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowith BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA, CATIE-AD Study Group Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med. 2006;355:1525–1538. doi: 10.1056/NEJMoa061240.
    1. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62:1172–1181.
    1. Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM, Normand SL, Mamdani M, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH. Atypical Antipsychotics and Parkinsonism. Arch Intern Med. 2005;165:1882–1888. doi: 10.1001/archinte.165.16.1882.
    1. Douglas IJ, Smeeth L. Exposure to antipsychotic and risk of stroke: self-controlled case series study. BMJ. 2008;337:a1227. doi: 10.1136/bmj.a1227.
    1. Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146:775–786.
    1. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934–1943. doi: 10.1001/jama.294.15.1934.
    1. Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkälä KH. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry. 2007;15:416–424. doi: 10.1097/JGP.0b013e31802d0b00.
    1. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005;353:2335–2341. doi: 10.1056/NEJMoa052827.
    1. Kallin K, Gustafson Y, Sandman PO, Karlsson S. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res. 2004;16:270–276.
    1. Ray WA, Thapa PB, Gideon PJ. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc. 2000;48:682–685.
    1. Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes- diagnostic indications and variations between institutions. Eur J Clin Pharmacol. 2001;57:523–528.
    1. Stelzner G, Riedel-Heller SG, Sonntag A, Matschinger H, Jakob A, Angermeyer MC. Determinants of psychotropic drug utilisation in homes for the elderly and nursing homes. [Article in German] Z Gerontol Geriatr. 2001;34:306–312. doi: 10.1007/s003910170054.
    1. Sorensen L, Foldspang A, Gulmann NC, Munk-Jørgensen P. Determinants fort he use of psychotropics among nursing home residents. Int J Geriatr Psychiatry. 2001;16:147–154. doi: 10.1002/1099-1166(200102)16:2<147::AID-GPS286>;2-4.
    1. Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora KS, Wodchis WP, Hillmer M, Kopp A, Gurwitz JH, Anderson GM. Variations in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167:676–683. doi: 10.1001/archinte.167.7.676.
    1. Bundesgesetzblatt für die Republik Österreich. Teil I, 11, Bundesgesetz. Austrian Ministry of Social Welfare, Vienna; 2004. Heimaufenthaltsgesetz (HeimAufG), (NR: GP XXII RV 353 AB 378 S. 46. BR:6966, 705)
    1. Mann E, Meyer G. Chemical restraints in nursing homes in the federal state Vorarlberg, Austria – an analysis of nursing home documentation according to legal obligation and suggestions for future improvement. [Article in German] Wien Med Wochenschr. 2008;158:489–492. doi: 10.1007/s10354-008-0549-4.
    1. World Health Organisation . Anatomical Therapeutic Chemical (ATC) classification index including defined daily doses (DDDs) for plain substances. World Health Organisation Collaborating Centre for Drug Statistics Methodology, Oslo; 1997.
    1. Federal Act on Nursing Care [Bundespflegegesetz, BGBl. 110/1993, text of 19 January 1993] SOZDOK edition Austrian Ministry of Social Welfare, Vienna; 1998. p. 51.
    1. Köhler L, Weyerer S, Schäufele M. Proxy screening tools improve the recognition of dementia in old-age homes: results of a validation study. Age Aging. 2007;36:549–554. doi: 10.1093/ageing/afm108.
    1. Cohen-Mansfield J. Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated. J Am Geriatr Soc. 1986;34:722–727.
    1. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. London: Arnold; 2000.
    1. Kerry SM, Bland JM. Unequal cluster sizes for trials in English and Welsh general practice: implications for sample size calculations. Statistics in Medicine. 2001;20:377–390. doi: 10.1002/1097-0258(20010215)20:3<377::AID-SIM799>;2-N.
    1. Rogers WH. Regression standard errors in clustered samples. Stata Technical Bulletin. 1993;13:19–23.
    1. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometric. 2000;56:645–646. doi: 10.1111/j.0006-341X.2000.00645.x.
    1. van Dijk KN, de Vries CS, Berg PB van den, Brouwers JR, de Jong-van den Berg LT. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol. 2000;55:765–771. doi: 10.1007/s002280050012.
    1. Holmquist IB, Svensson B, Hoglund P. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol. 2003;59:669–676. doi: 10.1007/s00228-003-0679-y.
    1. Feng Z, Hirdes JP, Smith TF, Finne-Soveri H, Chi I, Du Pasquier JN, Gilgen R, Ikegami N, Mor V. Use of physical restraints and antipsychotic medications in nursing homes: a cross-national study. Int J Geriatr Psychiatry. 2009
    1. Rapoport M. Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry. 2005;20:749–753. doi: 10.1002/gps.1358.
    1. Alexopoulos GS, Streim J, Carpenter D, Docherty JP. Expert Consensus Panel for Using antipsychotic agents in older patients. J Clin Psychiatry. 2004;65 Suppl 2:5–99.
    1. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews. 2006. p. CD003476. DOI: 10.1002/14651858.CD003476.pub2.
    1. Oborne CA, Hooper R, Li KC, Swift CG, Jackson SH. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing. 2002;31:435–439. doi: 10.1093/ageing/31.6.435.
    1. Hughes CM, Lapane KL, Mor V. Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care. 2000;38:1164–1173. doi: 10.1097/00005650-200012000-00003.
    1. Schmidt I, Claesson C, Westerholm B, Svarstadt BL. Resident and organisational factors affecting the quality of drug use in Swedish nursing homes. Soc Sci Med. 1998;47:961–971. doi: 10.1016/S0277-9536(98)00169-5.
    1. Svarstadt BL, Mount JK, Bigelow W. Variations in the Treatment Culture of nursing homes and responses to regulations to reduce drug use. Psychiatric Services. 2001;52:666–672. doi: 10.1176/appi.ps.52.5.666.
    1. Fick DM, Cooper JW, Wade WE. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716–2724. doi: 10.1001/archinte.163.22.2716.
    1. Hosia-Randell H, Muurinen S, Pitkälä KH. Exposure to Inappropriate Drugs and Drug Interactions in Elderly Nursing Home Residents in Helsinki, Finland. Drugs Ageing. 2008;25:683–692. doi: 10.2165/00002512-200825080-00005.
    1. Craig D, Passmore AP, Fullerton KJ, Beringer TR, Gilmore DH, Crawford VL, McCaffrey PM, Montgomery A. Factors influencing prescription of CNS medications in different elderly populations. Pharmacoepidemiol Drug Saf. 2003;12:383–387. doi: 10.1002/pds.865.
    1. Wallner J. Report on sustainability. [Article in German] Vol. 264. Dachverband der Alten- und Pflegeheime Österreichs, Ottakringer Straße, Wien; 2006. p. 1160.
    1. French D, Campbell R, Spehar AM, Accomando J. How Well do Psychotropic Medications Match Mental Health Diagnoses? A National View of Potential Off-Label Prescribing in VHA Nursing Homes. Age and Ageing. 2007;36:107–108. doi: 10.1093/ageing/afl131.
    1. Welz-Barth A, Hader C. Geriatric Assessment. [Article in German] Dtsch Med Wochenschr. 2007;132:827–836. doi: 10.1055/s-2007-973629.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する